Back to News
Market Impact: 0.38

Raymond James upgrades Voya Financial stock rating on M&A potential

Corporate EarningsAnalyst InsightsCompany FundamentalsM&A & RestructuringCapital Returns (Dividends / Buybacks)
Raymond James upgrades Voya Financial stock rating on M&A potential

Raymond James upgraded Voya Financial to Strong Buy from Market Perform and set a $117 target, implying material upside from the current $86.69 share price. The firm highlighted multiple rerating paths, including a potential sale of the Stop Loss business for more than $2 billion that could drive 8% to 19% EPS accretion through buybacks. Voya also posted Q1 2026 adjusted operating EPS of $2.26, ahead of the $2.06 estimate, though growth concerns and lower longer-term earnings estimates temper the bullish view.

Analysis

This is less a simple rerating story than a corporate control + capital allocation optionality trade. The market is effectively being offered three paths to monetization: keep compounding, strip out a structurally underappreciated asset, or force a strategic process. That combination usually compresses the gap between trading multiple and private-market value because it creates a floor under valuation even if standalone growth stays merely adequate.

The key second-order effect is that divestiture could make the remaining business look more like a clean retirement/asset-light financial compounder, which is the multiple expansion lever—not the sale price itself. If Stop Loss is monetized into buybacks at a depressed multiple, per-share math improves more than headline earnings, and that matters because this name appears to be trading on skepticism about quality rather than outright earnings weakness. The market may be underestimating how quickly capital return can reset the narrative if management gets aggressive post-sale.

The main risk is timing slippage: strategic premium can disappear if the process drags while the core segment remains a valuation overhang. In that case, the stock likely trades sideways-to-down for months even if earnings print well, because the market will anchor on execution risk rather than forecast EPS. A second risk is that a transaction happens at a price that looks good optically but is mediocre on repurchase accretion if the stock rerates before the deal closes.

Consensus may be missing that this is not just about who buys the company; it is about who can tolerate the capital intensity of the legacy business and extract better returns from the released capital. If the buyer universe is broad, that itself raises the probability of a process, but also increases the odds of a higher-and-better bid or a stand-alone re-rating. In that setup, the downside appears more limited than the upside, especially over a 6-12 month horizon.